Multiple myeloma has been considered a weakly immunogenic malignancy that can cause profound defects in the immune system. An important issue for the immunotherapy of myeloma is the identification of appropriate tumor-associated antigens (TAAs). Recently, hTERT (human telomerase reverse transcriptase) was detected on a majority of human malignancies. In the studies reported here, we studied antigen-specific and HLA-A2-restricted cytotoxic activity against an ARH77 myeloma cell line in vitro. An HLA-A2-specific hTERT-derived nonapeptide ((540)ILAKFLHWL(548)) was used as a TAA. Myeloma-specific cytotoxic activity of hTERT-reactive cytotoxic lymphocytes (CTLs) was established by repeated stimulation of the CTLs via dendritic cells loaded with hTERT-derived nonapeptide. These studies were able to demonstrate that hTERT-reactive T-lymphocytes can be identified and expanded using relatively simple in vitro techniques consisting of antigen-specific stimulation, immunomagnetic sorting, and then induction of rapid expansion.

Department of Hemato oncology University Hospital Brno Brno Czech Republic

Department of Pediatrics University Hospital Brno Brno Czech Republic

University Cell Immunotherapy Center Masaryk University Brno Czech Republic

University Research Centre The Czech Myeloma Group Masaryk University Brno Czech Republic

000      

02633naa a2200433 a 4500

001      

bmc12008664

003      

CZ-PrNML

005      

20170502114449.0

008      

120316s2009 xxk eng||

009      

AR

040    __

$a ABA008 $b cze $d ABA008

041    0_

$a eng

044    __

$a xxk

100    1_

$a Kryukov, Fedor $u University Cell Immunotherapy Center, Masaryk University, Brno, Czech Republic. f.kyukov@gmail.com; University Research Centre - The Czech Myeloma Group, Masaryk University, Brno, Czech Republic $7 xx0128646

245    10

$a In vitro activation of cytotoxic T-lymphocytes by hTERT-pulsed dendritic cells / $c Fedor Kryukov, Darina Očadlíková, Lucie Kovářová, Ivana Burešová, Roman Hájek, Jaroslav Michálek

520    9_

$a Multiple myeloma has been considered a weakly immunogenic malignancy that can cause profound defects in the immune system. An important issue for the immunotherapy of myeloma is the identification of appropriate tumor-associated antigens (TAAs). Recently, hTERT (human telomerase reverse transcriptase) was detected on a majority of human malignancies. In the studies reported here, we studied antigen-specific and HLA-A2-restricted cytotoxic activity against an ARH77 myeloma cell line in vitro. An HLA-A2-specific hTERT-derived nonapeptide ((540)ILAKFLHWL(548)) was used as a TAA. Myeloma-specific cytotoxic activity of hTERT-reactive cytotoxic lymphocytes (CTLs) was established by repeated stimulation of the CTLs via dendritic cells loaded with hTERT-derived nonapeptide. These studies were able to demonstrate that hTERT-reactive T-lymphocytes can be identified and expanded using relatively simple in vitro techniques consisting of antigen-specific stimulation, immunomagnetic sorting, and then induction of rapid expansion.

590    __

$a bohemika - dle Pubmed

650    02

$a antigeny nádorové $x imunologie $7 D000951

650    02

$a nádorové buněčné linie $7 D045744

650    02

$a dendritické buňky $x imunologie $7 D003713

650    02

$a lidé $7 D006801

650    02

$a aktivace lymfocytů $7 D008213

650    02

$a mnohočetný myelom $x imunologie $7 D009101

650    02

$a peptidové fragmenty $x genetika $x imunologie $7 D010446

650    02

$a cytotoxické T-lymfocyty $x imunologie $7 D013602

650    02

$a telomerasa $x genetika $x imunologie $x metabolismus $7 D019098

650    02

$a transdukce genetická $7 D014161

650    02

$a transfekce $7 D014162

655    _2

$a práce podpořená grantem $7 D013485

700    1_

$a Očadlíková, Darina $u University Cell Immunotherapy Center, Masaryk University, Brno, Czech Republic; University Research Centre - The Czech Myeloma Group, Masaryk University, Brno, Czech Republic $7 xx0181164

700    1#

$a Kovářová, L. $u University Cell Immunotherapy Center, Masaryk University, Brno, Czech Republic; University Research Centre - The Czech Myeloma Group, Masaryk University, Brno, Czech Republic $7 _AN073012

700    1#

$a Burešová, Ivana $u University Cell Immunotherapy Center, Masaryk University, Brno, Czech Republic; University Research Centre - The Czech Myeloma Group, Masaryk University, Brno, Czech Republic $7 _AN046426

700    1_

$a Hájek, Roman, $u University Research Centre - The Czech Myeloma Group, Masaryk University, Brno, Czech Republic; Department of Hemato-oncology, University Hospital Brno, Brno, Czech Republic $d 1964- $7 nlk20000083645

700    1_

$a Michálek, Jaroslav, $u University Cell Immunotherapy Center, Masaryk University, Brno, Czech Republic; Department of Pediatrics, University Hospital Brno, Brno, Czech Republic $d 1946- $7 ola2003201128

773    0_

$t Journal of Immunotoxicology $p J. immunotoxicol. $g Roč. 6, č. 4 (2009), s. 243-248 $w MED00188773 $x 1547-691X

773    0_

$p J. immunotoxicol. $g 6(4):243-8, 2009 Dec

910    __

$a ABA008 $b x $y 4 $z 0

990    __

$a 20120319124613 $b ABA008

991    __

$a 20170502114815 $b ABA008

999    __

$a ok $b bmc $g 902006 $s 765559

BAS    __

$a 3

BMC    __

$a 2009 $b 6 $c 4 $d 243-248 $m Journal of immunotoxicology $x MED00188773 $i 1547-691X $n J Immunotoxicol

GRA    __

$a 1A8709 $p MZ0

LZP    __

$a 2012-1Q10/